XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Net revenue $ 88,412 $ 93,947 $ 252,143 $ 211,959
Cost of revenue 56,213 65,755 164,771 144,004
Gross profit 32,199 28,192 87,372 67,955
Operating expenses:        
Research and product development 11,707 9,033 34,788 27,238
Selling, marketing, general and administrative 19,539 16,795 69,619 43,472
Restructuring and other charges 6,754   12,098  
Impairment of long-lived assets     1,735  
Amortization of intangible assets 312 387 888 1,130
Total operating expenses 38,312 26,215 119,128 71,840
Operating income (loss) (6,113) 1,977 (31,756) (3,885)
Interest income 20 14 81 98
Interest expense (49) (446) (326) (1,503)
Loss on extinguishment of debt       (1,369)
Other income (expense), net 922 (41) 1,633 69
Income (loss) before income taxes (5,220) 1,504 (30,368) (6,590)
Income tax provision (benefit) 676 1,619 2,032 2,452
Net income (loss) (5,896) (115) (32,400) (9,042)
Foreign currency translation adjustments (2,036) 1,112 (4,090) (1,519)
Actuarial gain (loss)     55 285
Comprehensive income (loss) $ (7,932) $ 997 $ (36,435) $ (10,276)
Net income (loss) per share        
Basic $ (0.22) $ (0.01) $ (1.22) $ (0.42)
Diluted $ (0.22) $ (0.01) $ (1.22) $ (0.42)
Weighted average shares outstanding used to compute basic net income (loss) per share 27,201 21,592 26,484 21,532
Weighted average shares outstanding used to compute diluted net income (loss) per share 27,201 21,592 26,484 21,532